Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 8Neoplasms 4Lung Neoplasms 4Glioma 4Neoplasm Metastasis 3Glioblastoma 3Colorectal Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Esophageal Neoplasms 2Carcinoma, Medullary 2Breast Neoplasms 2Adenocarcinoma 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1

Interventions

Fluorouracil 71pembrolizumab 62Bevacizumab 60Oxaliplatin 59Cetuximab 59Leucovorin 56Irinotecan 55Capecitabine 31Nivolumab 23Gemcitabine 18Cisplatin 18IFL protocol 17Folfox protocol 17Cyclophosphamide 16Carboplatin 15atezolizumab 14Specimen Handling 14Paclitaxel 14Magnetic Resonance Spectroscopy 14Biopsy 14trifluridine tipiracil drug combination 12Pemetrexed 10spartalizumab 9regorafenib 9fludarabine 9Panitumumab 9130-nm albumin-bound paclitaxel 9trametinib 8durvalumab 8dehydroftorafur 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Colorectal Neoplasms × vandetanib × Clear all
NCT00496509 2016-08-26

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Sanofi

Phase 1 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00436072 2012-10-04

ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

Dana-Farber Cancer Institute

Phase 1 Completed
46 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00532909 2012-07-16

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Stanford University

Phase 1 Completed
13 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡